Calendar of Events
M Mon
T Tue
W Wed
T Thu
F Fri
S Sat
S Sun
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
1 event,
14th European Paediatric Neurology Society Congress
The 14th European Paediatric Neurology Society Congress, to be held under the overarching theme "Precision in Child Neurology" from 28 April - 2 May 2022 in Glasgow (UK) and virtually, provides an opportunity to learn about the latest developments in the rapidly evolving field of child neurology including basic science, diagnostic methods and novel treatments. […]
3 events,
EMSP Annual Conference 2022: ‘’A Holistic Approach for Personalised MS Care’’
The EMSP Annual Conference 2022 will take place on 29-30 April 2022 in hybrid format, virtually and in person in Madrid, Spain. The theme of this year’s conference is ”A Holistic Approach for Personalised MS Care”. The personalised care model seeks to deliver whole-population approaches to support people of all ages and their carers to […]
Promoting Child Neurology in Europe | EPNS Congress 2022
Promoting Child Neurology in Europe | EPNS Congress 2022
On 29 April 2022, Joke Jaarsma, Treasurer of the European Brain Council, will hold a presentation on "Promoting child neurology in Europe" in the context of the 14th Congress of the European Paediatric Neurology Society (EPNS) in Glasgow. The EPNS Congress provides an opportunity to learn about the latest developments in the rapidly evolving […]
3 events,
Value of Treatment (VOT) case study on ataxia | EPNS Congress 2022
Value of Treatment (VOT) case study on ataxia | EPNS Congress 2022
The Value of Treatment for Brain Disorders (VOT) is a health economics and outcomes research project coordinated by the European Brain Council (EBC). According to the World Health Organization, disorders of the brain affect up to one in three people worldwide. A second round (VOT2) on new therapeutic areas was launched in 2019, focusing on The Value […]